Institute for the Advancement of Community Pharmacy Names Senior Fellow to Focus on Quality and Safe Medication Use Initiatives

Pfizer Inc Provides Major Grant to Support Fellowship



Apr 17, 2001, 01:00 ET from Institute for the Advancement of Community Pharmacy

    ALEXANDRIA, Va., April 17 /PRNewswire/ -- The Institute for the
 Advancement of Community Pharmacy announced today that Eleanor Vogt, RPh, PhD
 has been named Senior Fellow.  In this capacity, Dr. Vogt will spearhead the
 development of "hands-on" educational tools for consumers and community
 pharmacies in coordination with the staff of both the National Association of
 Chain Drug Stores (NACDS) and the National Community Pharmacists Association
 (NCPA).
     "The American public recognizes the pharmacist as protector, expert and
 confidant regarding the use of medications," stated Craig Fuller, Co-Chair of
 the Institute and President and CEO of NACDS.  "The critical 'safety net'
 services provided by community pharmacists, who serve as the patient's
 advocate and trusted health care professional, are vital to ensuring quality
 care and the patient's safe use of medications."
     "We will help pharmacies, regulators, and others understand and implement
 the 'new look' of patient safety, which emphasizes a systems approach to
 maximizing the quality of services and care," stated Laura Cranston, the
 Institute's Executive Director.
     Calvin Anthony, Co-Chair of the Institute and Executive Vice President of
 NCPA, stated, "More sophisticated and complex care is being delivered in the
 community pharmacy setting than ever before. That brings with it the
 responsibility to ensure that pharmacies and pharmacists have the tools they
 need to protect patients' safety, as well as their privacy, trust and
 confidence.  We are extremely pleased," he added,  "to have the commitment of
 Pfizer Inc as a partner in our endeavor to develop novel tools to ensure
 quality care and patients' safe use of medications."
     Eleanor Vogt most recently served as Senior Fellow at the National Patient
 Safety Foundation (NPSF) from 1997 through 2000.  She developed the
 Foundation's Regional Forum series and the precedent-setting Pharmaceutical
 Safe Use Initiative. Prior to NPSF, Dr. Vogt was Vice President for Public
 Affairs at the National Pharmaceutical Council for 12 years.  In addition, as
 a pharmacist-educator Dr. Vogt has held positions within academia, state and
 federal regulatory agencies, medical center administration, and professional
 and consumer organizations.
     The Institute received a two-year grant from Pfizer to support this
 fellowship. Joseph Feczko, MD, Senior Vice President for Medical and
 Regulatory Operations at Pfizer emphasized,  "We are committed to building a
 'culture of safety.'  As a pharmaceutical company, we believe that quality
 patient care must be safe, efficient and effective care, and we look forward
 to working in partnership with community pharmacy in achieving this common
 goal."
 
     The Institute for the Advancement of Community Pharmacy was founded by the
 National Association of Chain Drug Stores and the National Community
 Pharmacists Association in 1998 to advance the practice of community pharmacy
 in the United States.  The Institute funds educational initiatives, research
 projects, programs and activities to increase the number of community
 pharmacists and to promote the role and value of community pharmacy services.
 Collectively, NACDS and NCPA members operate over 52,000 community pharmacies
 with over 128,000 pharmacists.
 
 

SOURCE Institute for the Advancement of Community Pharmacy
    ALEXANDRIA, Va., April 17 /PRNewswire/ -- The Institute for the
 Advancement of Community Pharmacy announced today that Eleanor Vogt, RPh, PhD
 has been named Senior Fellow.  In this capacity, Dr. Vogt will spearhead the
 development of "hands-on" educational tools for consumers and community
 pharmacies in coordination with the staff of both the National Association of
 Chain Drug Stores (NACDS) and the National Community Pharmacists Association
 (NCPA).
     "The American public recognizes the pharmacist as protector, expert and
 confidant regarding the use of medications," stated Craig Fuller, Co-Chair of
 the Institute and President and CEO of NACDS.  "The critical 'safety net'
 services provided by community pharmacists, who serve as the patient's
 advocate and trusted health care professional, are vital to ensuring quality
 care and the patient's safe use of medications."
     "We will help pharmacies, regulators, and others understand and implement
 the 'new look' of patient safety, which emphasizes a systems approach to
 maximizing the quality of services and care," stated Laura Cranston, the
 Institute's Executive Director.
     Calvin Anthony, Co-Chair of the Institute and Executive Vice President of
 NCPA, stated, "More sophisticated and complex care is being delivered in the
 community pharmacy setting than ever before. That brings with it the
 responsibility to ensure that pharmacies and pharmacists have the tools they
 need to protect patients' safety, as well as their privacy, trust and
 confidence.  We are extremely pleased," he added,  "to have the commitment of
 Pfizer Inc as a partner in our endeavor to develop novel tools to ensure
 quality care and patients' safe use of medications."
     Eleanor Vogt most recently served as Senior Fellow at the National Patient
 Safety Foundation (NPSF) from 1997 through 2000.  She developed the
 Foundation's Regional Forum series and the precedent-setting Pharmaceutical
 Safe Use Initiative. Prior to NPSF, Dr. Vogt was Vice President for Public
 Affairs at the National Pharmaceutical Council for 12 years.  In addition, as
 a pharmacist-educator Dr. Vogt has held positions within academia, state and
 federal regulatory agencies, medical center administration, and professional
 and consumer organizations.
     The Institute received a two-year grant from Pfizer to support this
 fellowship. Joseph Feczko, MD, Senior Vice President for Medical and
 Regulatory Operations at Pfizer emphasized,  "We are committed to building a
 'culture of safety.'  As a pharmaceutical company, we believe that quality
 patient care must be safe, efficient and effective care, and we look forward
 to working in partnership with community pharmacy in achieving this common
 goal."
 
     The Institute for the Advancement of Community Pharmacy was founded by the
 National Association of Chain Drug Stores and the National Community
 Pharmacists Association in 1998 to advance the practice of community pharmacy
 in the United States.  The Institute funds educational initiatives, research
 projects, programs and activities to increase the number of community
 pharmacists and to promote the role and value of community pharmacy services.
 Collectively, NACDS and NCPA members operate over 52,000 community pharmacies
 with over 128,000 pharmacists.
 
 SOURCE  Institute for the Advancement of Community Pharmacy